Association of androgenetic alopecia with mortality from diabetes mellitus and heart disease.

IMPORTANCE Identifying predictors of mortality from diabetes mellitus (DM) and heart disease can help shape treatment strategies. Presence of androgenetic alopecia (AGA) might be such a predictor. OBJECTIVE To determine whether the presence of AGA is associated with an elevated rate of mortality from DM and heart disease in both sexes after adjustment for potential confounders. DESIGN A population-based prospective cohort study. SETTING Community-based integrated screening in Taiwan. PARTICIPANTS A total of 7252 subjects aged 30 to 95 years participated in the baseline AGA survey using the Norwood and Ludwig classifications between April and June 2005. Baseline information on metabolic syndrome (MetS) and other possible risk factors was also collected. We then followed this cohort over time to ascertain death and cause of death until December 2010. INTERVENTIONS OR EXPOSURES: Application of Norwood and Ludwig ALA classifications to study population. MAIN OUTCOMES AND MEASURES Deaths from DM and heart disease. RESULTS Among the 7126 subjects (2429 men and 4697 women) who provided complete data, there were 70 deaths from DM and heart disease during the 57-month follow-up period. Subjects with moderate to severe AGA vs normal or mild AGA had a significantly higher risk of mortality from DM (adjusted hazard ratio [HR], 2.97; 95% CI, 1.26-7.01) (P = .01) and heart disease (adjusted HR, 2.28; 95% CI, 1.00-5.23) (P = .05) after adjusting for age, family history of DM or heart disease, and MetS. CONCLUSIONS AND RELEVANCE AGA is an independent predictor of mortality from DM and heart disease in both sexes. This finding may have significant implications for the identification of risk factors for DM and heart disease in patients with moderate or severe AGA, regardless of whether MetS is present.

[1]  S. Keinänen-Kiukaanniemi,et al.  Early androgenetic alopecia as a marker of insulin resistance , 2000, The Lancet.

[2]  A. Rebora,et al.  Baldness and coronary artery disease: the dermatologic point of view of a controversial issue. , 2001, Archives of dermatology.

[3]  S. Harrap,et al.  Male pattern baldness is not associated with established cardiovascular risk factors in the general population. , 2001, Clinical science.

[4]  J. M. Nixon,et al.  Factors discriminating men with coronary heart disease from healthy controls. , 1972, British heart journal.

[5]  N. Savaş,et al.  Is androgenetic alopecia a risk for atherosclerosis? , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

[6]  M. Yen,et al.  Community‐based multiple screening model , 2004, Cancer.

[7]  S. Şaşmaz,et al.  The risk of coronary heart disease in men with androgenetic alopecia , 1999, Journal of the European Academy of Dermatology and Venereology : JEADV.

[8]  A. Sadighha,et al.  Evaluation of lipid levels in androgenetic alopecia in comparison with control group , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

[9]  J. Mckenney,et al.  Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II) , 1993, JAMA.

[10]  R. D'Agostino,et al.  Baldness and coronary heart disease rates in men from the Framingham Study. , 1995, American journal of epidemiology.

[11]  J. Manson,et al.  Male pattern baldness and coronary heart disease: the Physicians' Health Study. , 2000, Archives of internal medicine.

[12]  B. Crickx,et al.  Association of androgenetic alopecia and hypertension. , 2007, European journal of dermatology : EJD.

[13]  S. Keinänen-Kiukaanniemi,et al.  Early Onset of Androgenetic Alopecia Associated With Early Severe Coronary Heart Disease: A Population-Based, Case-Control Study , 2001, Journal of cardiovascular risk.

[14]  J. Ocampo-Candiani,et al.  Androgenetic alopecia and insulin resistance in young men , 2009, Clinical endocrinology.

[15]  E. Ludwig Classification of the types of androgenetic alopecia (common baldness) occurring in the female sex , 1977, The British journal of dermatology.

[16]  Lin-Hui Su,et al.  Association of androgenetic alopecia with metabolic syndrome in men: a community‐based survey , 2010, The British journal of dermatology.

[17]  V. Krogh,et al.  Baldness and coronary heart disease risk factors. , 1993, Journal of clinical epidemiology.

[18]  N. Cooke Male pattern alopecia and coronary artery disease in men , 1979, The British journal of dermatology.

[19]  S. Shapiro,et al.  A case-control study of baldness in relation to myocardial infarction in men. , 1993, JAMA.

[20]  Salvador Arias-Santiago,et al.  Androgenetic alopecia and cardiovascular risk factors in men and women: a comparative study. , 2010, Journal of the American Academy of Dermatology.

[21]  M. Szklo,et al.  Baldness and myocardial infarction in men: the atherosclerosis risk in communities study. , 2007, American journal of epidemiology.

[22]  S. Harrap,et al.  Insulin gene polymorphism and premature male pattern baldness in the general population. , 1999, Clinical science.

[23]  O. Norwood,et al.  Male Pattern Baldness: classification and Incidence , 1975, Southern medical journal.

[24]  T. Byers,et al.  Baldness and ischemic heart disease in a national sample of men. , 1996, American journal of epidemiology.